Search

Your search keyword '"Barbara Porowska"' showing total 2 results
Start Over Author "Barbara Porowska" Journal canadian journal of infectious diseases and medical microbiology
2 results on '"Barbara Porowska"'

1. Helicobacter pylori Infection and Gastric Dysbiosis: Can Probiotics Administration Be Useful to Treat This Condition?

Author

Giovanni Bruno, Giulia Rocco, Piera Zaccari, Barbara Porowska, Maria Teresa Mascellino, and Carola Severi

Subjects
Infectious and parasitic diseases, RC109-216, Microbiology, QR1-502
Abstract

Helicobacter pylori (Hp) is responsible for one of the most common infections in the world. The prevalence exceeds 50% of the population in developing countries, and approximately one-third of the adults are colonized in North Europe and North America. It is considered a major pathogenic agent of chronic gastritis, peptic ulcer, atrophic gastritis, gastric cancer, and mucosa-associated lymphoid tissue lymphoma (MALT). Hp colonization modifies the composition of gastric microbiota that could drive the development of gastric disorders. Currently, an emerging problem in Hp treatment is represented by the increasing rate of antimicrobial therapy resistance. In this context, the search for adjuvant agents can be very useful to overcome this issue and probiotics administration can represent a valid option. The aim of this review is to describe the gastric microbiota changes during Hp colonization, the mechanisms of action, and a possible role of probiotics in the treatment of this infection.

Published
2018
Full Text
View/download PDF

2. Helicobacter pylori Infection and Gastric Dysbiosis: Can Probiotics Administration Be Useful to Treat This Condition?

Author

Carola Severi, Barbara Porowska, Piera Zaccari, Giulia Rocco, G. Bruno, and Maria Teresa Mascellino

Subjects
0301 basic medicine, Microbiology (medical), Atrophic gastritis, Population, Chronic gastritis, Context (language use), Infectious and parasitic diseases, RC109-216, Review Article, Microbiology, 03 medical and health sciences, 0302 clinical medicine, medicine, education, education.field_of_study, biology, business.industry, Stomach, gastritis, Helicobacter pylori, medicine.disease, biology.organism_classification, QR1-502, digestive system diseases, gastritis, Helicobacter pylori eradication, gastric microbiota, gastric microbiota, 030104 developmental biology, Infectious Diseases, medicine.anatomical_structure, Immunology, 030211 gastroenterology & hepatology, Gastritis, medicine.symptom, business, Dysbiosis, Helicobacter pylori eradication
Abstract

Helicobacter pylori (Hp) is responsible for one of the most common infections in the world. The prevalence exceeds 50% of the population in developing countries, and approximately one-third of the adults are colonized in North Europe and North America. It is considered a major pathogenic agent of chronic gastritis, peptic ulcer, atrophic gastritis, gastric cancer, and mucosa-associated lymphoid tissue lymphoma (MALT). Hp colonization modifies the composition of gastric microbiota that could drive the development of gastric disorders. Currently, an emerging problem in Hp treatment is represented by the increasing rate of antimicrobial therapy resistance. In this context, the search for adjuvant agents can be very useful to overcome this issue and probiotics administration can represent a valid option. The aim of this review is to describe the gastric microbiota changes during Hp colonization, the mechanisms of action, and a possible role of probiotics in the treatment of this infection.

Published
2018

Catalog

Books, media, physical & digital resources
See catalog results